T43.013A Poisoning by tricyclic antidepressants, assault, initial encounter

Name of the Condition

• Poisoning by tricyclic antidepressants, assault, initial encounter
• Technical term: T43.013A

Summary

This code describes poisoning by tricyclic antidepressants resulting from an assault, with the encounter classified as initial. Tricyclic antidepressants (TCAs) are a class of medications used to treat depression and other mental health conditions. The code applies when clinical documentation confirms the poisoning was caused by an assault, distinguishing it from accidental, intentional self-harm, or therapeutic adverse effects. It is specific to the initial phase of care following the event.

Causes

Poisoning by tricyclic antidepressants in an assault context occurs when a patient is intentionally exposed to excessive doses of TCAs by another individual. This may involve forced ingestion, administration without consent, or tampering with medication. The assault must be documented as the cause of the poisoning for this code to be applied.

Risk Factors

• Exposure to situations involving interpersonal violence or coercion.
• Lack of supervision or control over medication access in vulnerable settings.
• History of abuse or exploitation.
• Social or environmental factors increasing the risk of assault.

Symptoms

Symptoms of tricyclic antidepressant poisoning can include:

• Altered mental status, confusion, or coma.
• Rapid heart rate, irregular heartbeat, or cardiac arrhythmias.
• Seizures, tremors, or muscle rigidity.
• Dry mouth, blurred vision, or urinary retention.
• Nausea, vomiting, or gastrointestinal distress.
• Hypotension or hypertension.

Diagnosis

Diagnosis requires confirmation of tricyclic antidepressant exposure, clinical assessment of poisoning symptoms, and documentation of the assault as the cause. Laboratory tests (e.g., drug levels) may support the diagnosis, but clinical correlation with the assault event is essential. The initial encounter phase is defined by the first contact for evaluation and treatment of the poisoning.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the toxic effects of tricyclic antidepressants. This may include airway support, cardiac monitoring, administration of activated charcoal (if appropriate), and specific antidotes (e.g., sodium bicarbonate for cardiac toxicity). Psychiatric evaluation and trauma-informed care are critical given the assault context.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying health status. Initial follow-up involves monitoring for complications and ensuring safety. Long-term care may include mental health support, trauma counseling, and coordination with social services to address the assault and prevent recurrence.

Complications

Potential complications include cardiac arrhythmias, seizures, respiratory depression, or multi-organ failure. Psychological effects from the assault, such as post-traumatic stress, may also occur and require ongoing management.

Lifestyle & Prevention

Prevention strategies include ensuring secure medication storage, avoiding situations with high assault risk, and seeking support for interpersonal violence. For healthcare providers, documenting the assault clearly and coordinating with legal or protective services is key to addressing the root cause.

When to Seek Professional Help

Seek immediate medical attention if poisoning symptoms (e.g., altered mental status, cardiac changes) occur after an assault. Report the assault to appropriate authorities and ensure the patient receives both medical and psychological support.

Tips for Medical Coders

Use this code only when documentation explicitly links the tricyclic antidepressant poisoning to an assault and the encounter is initial. Confirm the intent (assault) and timing (initial phase) to avoid misclassification. Ensure clinical notes support the cause and phase of care to justify code assignment.